DE69217597T2 - Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1 - Google Patents

Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1

Info

Publication number
DE69217597T2
DE69217597T2 DE69217597T DE69217597T DE69217597T2 DE 69217597 T2 DE69217597 T2 DE 69217597T2 DE 69217597 T DE69217597 T DE 69217597T DE 69217597 T DE69217597 T DE 69217597T DE 69217597 T2 DE69217597 T2 DE 69217597T2
Authority
DE
Germany
Prior art keywords
antibiotic
epsilon
characteristic
epsilon1
accompanying drawings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69217597T
Other languages
German (de)
English (en)
Other versions
DE69217597D1 (de
Inventor
Guy Thomas Carter
Joseph Jacob Goodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69217597D1 publication Critical patent/DE69217597D1/de
Publication of DE69217597T2 publication Critical patent/DE69217597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/232—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69217597T 1991-09-09 1992-06-29 Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1 Expired - Fee Related DE69217597T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/756,931 US5286745A (en) 1991-09-09 1991-09-09 Antibiotics LL-E19020 Epsilon and LL-E19020 Epsilon1

Publications (2)

Publication Number Publication Date
DE69217597D1 DE69217597D1 (de) 1997-04-03
DE69217597T2 true DE69217597T2 (de) 1997-07-10

Family

ID=25045662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69217597T Expired - Fee Related DE69217597T2 (de) 1991-09-09 1992-06-29 Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1

Country Status (16)

Country Link
US (1) US5286745A (enExample)
EP (1) EP0531641B1 (enExample)
JP (1) JPH05255365A (enExample)
KR (1) KR100266472B1 (enExample)
AT (1) ATE149174T1 (enExample)
AU (1) AU653250B2 (enExample)
CA (1) CA2077578A1 (enExample)
DE (1) DE69217597T2 (enExample)
DK (1) DK0531641T3 (enExample)
ES (1) ES2097834T3 (enExample)
GR (1) GR3023420T3 (enExample)
IE (1) IE80570B1 (enExample)
IL (1) IL103086A (enExample)
NZ (1) NZ244200A (enExample)
TW (1) TW200487B (enExample)
ZA (1) ZA926832B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100467588C (zh) * 2006-03-21 2009-03-11 北京市农林科学院 一株利迪链霉菌及其在植物病害生物防治中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US4704276A (en) * 1986-06-30 1987-11-03 American Cyanamid Company Compositions and methods for increasing the growth rate of meat producing animals, improving the efficiency of feed utilization thereby and enhancing lactation in lactating ruminants
US4705688A (en) * 1986-06-30 1987-11-10 American Cyanamid Company Antibiotic LL-E19020 α and β
FR2657873B1 (fr) * 1990-02-08 1992-04-17 Rhone Poulenc Sante Nouvelle elfamycine, son procede de preparation et son utilisation.

Also Published As

Publication number Publication date
IL103086A0 (en) 1993-02-21
IL103086A (en) 1997-04-15
ES2097834T3 (es) 1997-04-16
NZ244200A (en) 1993-12-23
KR930006042A (ko) 1993-04-20
US5286745A (en) 1994-02-15
IE922643A1 (en) 1993-03-10
JPH05255365A (ja) 1993-10-05
AU2283292A (en) 1993-03-11
TW200487B (enExample) 1993-02-21
KR100266472B1 (ko) 2000-09-15
ATE149174T1 (de) 1997-03-15
CA2077578A1 (en) 1993-03-10
DE69217597D1 (de) 1997-04-03
AU653250B2 (en) 1994-09-22
DK0531641T3 (da) 1997-05-05
EP0531641B1 (en) 1997-02-26
EP0531641A1 (en) 1993-03-17
GR3023420T3 (en) 1997-08-29
ZA926832B (en) 1993-03-15
IE80570B1 (en) 1998-09-23

Similar Documents

Publication Publication Date Title
DE69422526T2 (de) Polyzyklische antiparasitäre derivate, verfahren und stamm zu ihrer herstellung und ihrer verwendung
DE69021176T2 (de) Polypeptid und Verfahren zu dessen Herstellung.
DE3436137C2 (de) Antibiotika BBM-2478A und BBM-2478B, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
DE2718782C2 (enExample)
DE60110908T2 (de) Antibiotische tripropeptine und verfahren ihrer herstellung
DE69217597T2 (de) Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1
DE69223883T2 (de) Antibiotikum LL-E19020 Alpha
DE69816621T2 (de) Macrolide mit antitumoraktivität
DE69903465T2 (de) Vancoresmycin, verfahren zu dessen herstellung und dessen anwendung als arzneimittel
EP0236894B1 (de) Efomycin G, seine Herstellung und seine Verwendung als Leistungsförderer bei Tieren
DE69009923T2 (de) Antifungales Antibiotikum und seine Herstellung und Verwendung.
DE1620597A1 (de) Decoyinintriester und Verfahren zu ihrer Herstellung
DE69219841T2 (de) Antibiotikum LL-E19020 Zeta und Antibiotikum LL-E19020 Eta
DE68918071T2 (de) Antibiotikum A80915 und Verfahren zu seiner Herstellung.
DE69013809T2 (de) Antibiotikum.
DE69217000T2 (de) Antibakterielle Verbindung BE-24566B
DE69223302T2 (de) Antibiotikum LL-E19020 Gamma
DE69129924T2 (de) Antibiotikum und Verfahren zu seiner Herstellung
DE2652677A1 (de) Antibiotica 890a tief 1 und 890a tief 3
DE69720101T2 (de) Makrolid Verbindung 0406
EP0173948A2 (de) Neue Pseudooligosaccharide mit alpha-Glukosidase-hemmender Wirkung, Verfahren zur deren Herstellung, deren Verwendung und pharmazeutische Präparate
AT389516B (de) Neue oxiran-pseudooligosaccharide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate
DE4231289A1 (de) Neuer Naturstoff Cyclamenol und chemische Derivate
DE3889417T2 (de) Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln.
DE69804689T2 (de) Terpenoid Verbindung 0406TP-1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee